Acute Coronary Syndrome Remodels the Protein Cargo and Functions of High-Density Lipoprotein Subfractions-Reference-Cited by-同舟云学术

Acute Coronary Syndrome Remodels the Protein Cargo and Functions of High-Density Lipoprotein Subfractions

Published:2014-04-15 Issue:4 Volume:9 Page:e94264
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Tan Ying,Liu Ting Rong,Hu Shui Wang,Tian Di,Li Chen,Zhong Jian Kai,Sun Hai Ge,Luo Tian Tian,Lai Wen Yan,Guo Zhi-Gang

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference38 articles.

1. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies;DJ Gordon;Circulation,1989

2. Update on strategies to increase HDL quantity and function;D Duffy;Nature Reviews Cardiology,2009

3. Beyond high-density lipoprotein cholesterol levelsevaluating high-density lipoprotein function as influenced by novel therapeutic approaches;DJ Rader;Journal of the American College of Cardiology,2008

4. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis;AV Khera;New England Journal of Medicine,2011

5. Laboratory investigation of dysfunctional HDL;ZG Guo;Chemistry and Physics of Lipids,2012

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The mediation effect of HDL-C: Non-HDL-C on the association between inflammatory score and recurrent coronary events;Heliyon;2024-01

2. Searching for Atherosclerosis Biomarkers by Proteomics: A Focus on Lesion Pathogenesis and Vulnerability;International Journal of Molecular Sciences;2023-10-14

3. Proteomic and functional analysis of HDL subclasses in humans and rats: a proof-of-concept study;Lipids in Health and Disease;2023-06-29

4. Apoproteins and Cell Surface Receptors Regulating Lipoprotein Metabolism in the Setting of Type 2 Diabetes;Contemporary Diabetes;2023

5. Apolipoprotein Signature of HDL and LDL from Atherosclerotic Patients in Relation with Carotid Plaque Typology: A Preliminary Report;Biomedicines;2021-09-03